The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?

Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited

(2017) Micaela Mathiak et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma

(2016) Yuta Kondo et al.   ORAL ONCOLOGY

Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder

(2016) Christine Böger et al.   PATHOLOGY RESEARCH AND PRACTICE

PD-L1 is an independent prognostic predictor in gastric cancer of Western patients

(2016) Christine Böger et al.   Oncotarget

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

(2016) D. B. Johnson et al.   Cancer Immunology Research

Immunotherapy for Gastroesophageal Cancer

(2016) Emily Goode et al.   Journal of Clinical Medicine

Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation

(2016) Patrícia Oliveira et al.   Scientific Reports

MET in gastric cancer - discarding a 10% cutoff rule

(2015) Marie-Luise Metzger et al.   HISTOPATHOLOGY

Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites

(2015) O. Gumusay et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Clinicopathological characteristics ofRHOAmutations in a Central European gastric cancer cohort

(2015) Christoph Röcken et al.   JOURNAL OF CLINICAL PATHOLOGY

Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses

(2015) Jun Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immune evasion in cancer: Mechanistic basis and therapeutic strategies

(2015) Dass S. Vinay et al.   SEMINARS IN CANCER BIOLOGY

VISTA Is an Immune Checkpoint Molecule for Human T Cells

(2014) J. L. Lines et al.   CANCER RESEARCH

VISTA Regulates the Development of Protective Antitumor Immunity

(2014) I. Le Mercier et al.   CANCER RESEARCH

Comprehensive molecular characterization of gastric adenocarcinoma

(2014) Adam J. Bass et al.   NATURE

Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer

(2014) Kai Wang et al.   NATURE GENETICS

VISTA Is a Novel Broad-Spectrum Negative Checkpoint Regulator for Cancer Immunotherapy

(2014) J. L. Lines et al.   Cancer Immunology Research

Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine

(2013) Viktoria S. Warneke et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

(2012) V. S. Warneke et al.   ANNALS OF ONCOLOGY

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses

(2011) Li Wang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Discovering the false discovery rate

(2010) Yoav Benjamini   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY

Differentiation of Embryonic Stem Cells 1 (Dies1) Is a Component of Bone Morphogenetic Protein 4 (BMP4) Signaling Pathway Required for Proper Differentiation of Mouse Embryonic Stem Cells

(2009) Luigi Aloia et al.   JOURNAL OF BIOLOGICAL CHEMISTRY